Your browser doesn't support javascript.
loading
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia.
Donnellan, William; Berdeja, Jesus G; Shipley, Diana; Arrowsmith, Edward R; Wright, David; Lunin, Scott; Brown, Richard; Essell, James H; Flinn, Ian W.
Afiliación
  • Donnellan W; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Berdeja JG; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Shipley D; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Arrowsmith ER; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Wright D; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Lunin S; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Brown R; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Essell JH; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Flinn IW; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
Oncologist ; 22(10): 1156-e111, 2017 10.
Article en En | MEDLINE | ID: mdl-28687625

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Anticuerpos Monoclonales / Antineoplásicos Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Anticuerpos Monoclonales / Antineoplásicos Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos